Latest News about TGTX
Recent news which mentions TGTX
FDA Puts Blood Cancer Nods Under Scrutiny On Substantial Toxicity Profile Of PI3K Drugs
April 21, 2022
From Benzinga
From InvestorPlace
68 Biggest Movers From Yesterday
April 19, 2022
From Benzinga
Mid-Afternoon Market Update: Crude Oil Rises Over 1%; Nektar Therapeutics Shares Slide
April 18, 2022
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
April 18, 2022
From Benzinga
From Benzinga
34 Stocks Moving In Monday's Mid-Day Session
April 18, 2022
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 18, 2022
From Benzinga
10 Biggest Price Target Changes For Monday
April 18, 2022
From Benzinga
21 Stocks Moving in Monday's Pre-Market Session
April 18, 2022
From Benzinga
The Week Ahead In Biotech (April 17-April 23): J&J, Abbott Earnings, Adcom Test For TG Therapeutics And More
April 17, 2022
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
April 12, 2022
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
March 15, 2022
From Benzinga
FDA Pushes TG Therapeutics' Ublituximab / Ukoniq Combo Therapy Applications In Blood Cancer Settings
March 03, 2022
Tickers
TGTX
From Benzinga
From Benzinga
Earnings Scheduled For March 1, 2022
March 01, 2022
From Benzinga
52 Biggest Movers From Friday
January 31, 2022
From Benzinga
64 Biggest Movers From Yesterday
January 28, 2022
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
January 27, 2022
From Benzinga
TG Therapeutics Falls 30% As CEO Discloses Partial Clinical Hold On Blood Cancer Trials
January 27, 2022
Tickers
TGTX
From Benzinga
46 Stocks Moving In Thursday's Mid-Day Session
January 27, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.